Table 1 Patients’ characteristics
HRMA WT | HRMA MUT | Total | |
|---|---|---|---|
Gender | |||
Male | 31 | 4 | 35 |
Female | 15 | — | 15 |
Age (median) | 61 | 66 | |
Primary tumour | |||
Colon | 30 | 1 | 31 |
Rectum | 16 | 3 | 19 |
No. of prior lines of treatment | |||
1 | 26 | 2 | 28 |
2 | 20 | 2 | 22 |
Sites of metastases | |||
Liver only | 18 | 2 | 20 |
Lung only | 8 | 1 | 9 |
Multiple site | 20 | 1 | 21 |
Cetuximab-containing regimen | |||
Irinotecan | 23 | 2 | 25 |
FOLFIRI | 20 | 2 | 22 |
FOLFOX | 3 | — | 3 |
